NIH-funded research R01 grant

Investigating how protein regulation affects Alzheimer's-like symptoms in Down syndrome

Official title: Proteostasis dysregulation and the development of Alzheimer's-like neurodegeneration and dementia in Down syndrome

Funded at Temple Univ of the Commonwealth · NIH-10979169 · Data updated 2026-11-12

This study is looking at how certain proteins in the brain might be linked to Alzheimer's-like changes in people with Down syndrome, and it hopes to find ways to help keep their brains healthier.

More Dementia research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTemple Univ of the Commonwealth
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startDecember 1, 2022
Project endNovember 30, 2027
Funding year2025
Award (this year)$489,358
NIH project number5R01AG080817-03
Project IDNIH-10979169 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with Down syndrome who may be at risk for developing Alzheimer's-like symptoms.

Less likely to help

Patients without Down syndrome or those who do not exhibit any signs of neurodegeneration may not benefit from this research.

What this research studies

This research focuses on understanding the relationship between protein regulation and the development of Alzheimer's-like neurodegeneration in individuals with Down syndrome. It examines how an overactive cellular process, known as mTOR, may contribute to brain changes associated with Alzheimer's disease. By studying both human subjects and a mouse model of Down syndrome, the research aims to uncover the mechanisms behind these changes and their impact on brain health. The findings could lead to new insights into preventing or treating neurodegeneration in this population.

Why it matters

Potential benefit: If successful, this research could lead to targeted therapies that improve brain health and reduce the risk of Alzheimer's disease in individuals with Down syndrome.

How similar studies have gone: Previous research has shown promising results in understanding the role of protein regulation in neurodegenerative diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Temple Univ of the Commonwealth
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Pratico, Domenico — Temple Univ of the Commonwealth
  • Study coordinator: Pratico, Domenico

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.